{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:07:32Z","timestamp":1792699652081,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.euo.2023.10.014","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T05:08:58Z","timestamp":1699592938000},"page":"537-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office"],"prefix":"10.1016","volume":"7","author":[{"given":"Joost L.","family":"Boormans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Anson-Cartwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Glicksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gedske","family":"Daugaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Lauritsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Avuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier Garc\u00eda","family":"del Muro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Stalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rothermundt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Pilar","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2023.10.014_b0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.eururo.2023.04.010","article-title":"European Association of Urology guidelines on testicular cancer: 2023 update","volume":"84","author":"Patrikidou","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.014_b0010","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2002.01.038","article-title":"Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis","volume":"20","author":"Warde","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.014_b0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/bju.14967","article-title":"Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis","volume":"125","author":"Blok","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2023.10.014_b0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.eururo.2017.09.025","article-title":"Testicular tumour size and rete testis invasion as prognostic factors for the risk of relapse of clinical stage I seminoma testis patients under surveillance: a systematic review by the Testicular Cancer Guidelines Panel","volume":"73","author":"Boormans","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.014_b0025","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.urolonc.2017.06.047","article-title":"Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance\u2014a systematic review","volume":"36","author":"Zengerling","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2023.10.014_b0030","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1200\/JCO.21.00637","article-title":"Testicular cancer in the cisplatin era: causes of death and mortality rates in a population-based cohort","volume":"39","author":"Hellesnes","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.014_b0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/bjc.2013.551","article-title":"Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma","volume":"110","author":"Horwich","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euo.2023.10.014_b0040","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.eururo.2014.07.001","article-title":"A nationwide cohort study of stage I seminoma patients followed on a surveillance program","volume":"66","author":"Mortensen","year":"2014","journal-title":"Eur Urol"},{"issue":"157","key":"10.1016\/j.euo.2023.10.014_b0045","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0022-5347(01)64839-0","article-title":"Prognostic factors for relapse in stage I testicular seminoma treated with surveillance","author":"Warde","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2023.10.014_b0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0360-3016(93)90415-R","article-title":"Results of a policy of surveillance in stage I testicular seminoma","volume":"27","author":"Warde","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2023.10.014_b0055","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00432-016-2162-z","article-title":"Testicular seminoma clinical stage 1: treatment outcome on a routine care level","volume":"142","author":"Dieckmann","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.014_b0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cam4.324","article-title":"Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance","volume":"4","author":"Chung","year":"2015","journal-title":"Cancer Med"},{"key":"10.1016\/j.euo.2023.10.014_b0065","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/cncr.30458","article-title":"Surveillance versus adjuvant radiotherapy for patients with high-risk stage I seminoma","volume":"123","author":"Mortensen","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2023.10.014_b0070","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/COC.0b013e318277d839","article-title":"Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort","volume":"37","author":"Soper","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.014_b0075","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41585-022-00624-y","article-title":"Biomarkers of disease recurrence in stage I testicular germ cell tumours","volume":"19","author":"Lesko","year":"2022","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2023.10.014_b0080","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.eururo.2015.07.044","article-title":"Guidelines on testicular cancer: 2015 update","volume":"68","author":"Albers","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2023.10.014_b0085","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.euo.2023.10.014_b0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1200\/JCO.2014.56.2116","article-title":"Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance","volume":"33","author":"Kollmannsberger","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.014_b0095","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/annonc\/mdw164","article-title":"Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)","volume":"27","author":"Tandstad","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2023.10.014_b0100","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1200\/JCO.2005.01.9810","article-title":"Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study","volume":"23","author":"Aparicio","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.014_b0105","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1200\/JCO.2011.36.0503","article-title":"Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study","volume":"29","author":"Aparicio","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2023.10.014_b0110","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/annonc\/mdu437","article-title":"Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG)","volume":"25","author":"Aparicio","year":"2014","journal-title":"Ann Oncol"},{"issue":"67","key":"10.1016\/j.euo.2023.10.014_b0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2023.10.014_b0120","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/bju.14618","article-title":"Sentinel node biopsy in clinical stage I testicular cancer enables early detection of occult metastatic disease","volume":"124","author":"Blok","year":"2019","journal-title":"BJU Int"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123002328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931123002328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T21:24:34Z","timestamp":1715808274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931123002328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2588931123002328"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2023.10.014","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2023.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}